Curacyte AG

https://www.curacyte.com

Curacyte AG is an advanced biopharmaceutical company dedicated to the development of new therapeutics for acute and critical care. Curacyte's lead product is Hemoximer (Pyridoxalated Hemoglobin Polyoxyethylene, PHP). Hemoximer has been developed as a scavenger of nitirc oxide, the causative agent responsible for vasodilation hypotension in shock.The ability to scavenge and metabolize NO is one of the important physiological functions of natural hemoglobin. Hemoximer has been demonstrated to reverse vasodilation and resolve hypotension associated with distributive shock and has completed the Phase II clinical development in this primary indication. Currently, a pivotal Phase III study to be conducted in patients suffering from distributive shock and not responding to standard therapy with catecholamines is being inititated in various European countries. Apart from distributive shock, hemoximer is also being studied as an adjunct to high-dose interleukin-2 (IL-2) for patiens with metastatic melanoma and renal cell carcinoma. Shock is a frequent dose-limiting side effect of high-dose IL-2 therapy. *

	Start	2001-02-01 established
	Group	Curacyte (Group)
	Industry	BIOTECH

	Region	München (Munich)
	Country	Germany
	Street	14 Grillparzer Str.
	City	81675 München
	Tel	+49-89-2000142-10
		Address record changed: 2020-12-02

Basic data	Employees	n. a.

		* Document for »About Section«:

		Record changed: 2025-03-16

Picture Informa Connect BioProcess Intl Europe 2025 Hamburg Register 650x200px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)